Blood pressure monitoring and control by cardiovascular disease status in UK primary care: 10 year retrospective cohort study

Size: px
Start display at page:

Download "Blood pressure monitoring and control by cardiovascular disease status in UK primary care: 10 year retrospective cohort study"

Transcription

1 Journal of Public Health Vol. 33, No. 2, pp doi: /pubmed/fdq078 Advance Access Publication 12 October 2010 Blood pressure monitoring and control by cardiovascular disease status in UK primary care: 10 year retrospective cohort study Anthony A. Laverty*, Alex Bottle, Azeem Majeed, Christopher Millett Department of Primary Care and Public Health, Imperial College London, St Dunstan s Road, London W6 8RP, UK *Address correspondence to Anthony Laverty, a.laverty@imperial.ac.uk ABSTRACT Background Strategies to reduce the burden of cardiovascular disease (CVD) in the UK have emphasized improved management of high-risk individuals rather than population-based approaches. Methods This 10-year retrospective cohort study examined blood pressure (BP) monitoring and control among patients with and without CVD in general practices in Wandsworth, London between 1998 and Logistic regression was used to assess associations among age, gender, ethnicity, deprivation and BP control. Results The percentage of patients with elevated BP (.140/90 mm Hg) decreased at a slower rate in patients without CVD ( %) compared with those with CVD ( %) (P, 0.001). Mean systolic BP decreased from to mm Hg in patients with CVD and from to in patients without CVD. Mean diastolic BP decreased from 84.2 to 78.4 mm Hg in patients with CVD and from 80.5 to 79.0 in patients without CVD. Inequalities in BP control decreased among age, ethnic and deprivation groups but increased between men and women without CVD. Conclusions Measurement and control of BP among those with CVD has improved much more rapidly compared with those without CVD. Inequalities in BP control appeared to increase between men and women without CVD, but decreased among age, ethnicity and deprivation groups. Keywords Circulatory disease, population-based and preventative services, primary care Introduction Elevated blood pressure (BP) is responsible for approximately half of the worldwide burden of cardiovascular disease (CVD). 1 Estimates suggest that eliminating poor BP control would prevent deaths from coronary heart disease (CHD) and stroke each year in the UK alone. 2 Moreover, improvements in BP control may reduce health inequalities as mortality from CVD has been shown to be three times higher in the most deprived areas of the UK in comparison to affluent areas. 3 Previous studies suggest that while a combination of strategies are required to reduce CVD mortality, the benefit derived from population-wide reductions in risk factors is greater than that associated with improved management of established cases. 4 While the UK has introduced some promising initiatives to reduce BP at the population level, including the Food Standard Agency s salt reduction strategy, 5 disproportionate emphasis may have been placed on improving the management of BP among high-risk groups. This is reflected in the National Service Frameworks for CHD 6 and Older People 7 and the increased investment in secondary prevention in primary care through the 2004 Anthony A. Laverty, Research Assistant Alex Bottle, Lecturer in Medical Statistics Azeem Majeed, Professor of Primary Care Christopher Millett, Senior Lecturer and Honorary Consultant in Public Health 302 # The Author 2010, Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved.

2 BLOOD PRESSURE CONTROL IN PRIMARY CARE 303 General Practitioner contract. More recently, the government introduced NHS Health Checks, a cardiovascular risk assessment programme, which aims to identify and manage adults at high risk of cardiovascular disease in England. 8 Detailed data on the prevalence of hypertension come from the Health Survey for England (HSE), which focused on cardiovascular disease in 1994, 1998, 2003 and These nationally representative surveys suggest that mean BP values in the population have been falling since 1994, and that there have been significant increases in rates of treatment and control among those with hypertension. 9 While data from the HSE are informative, they have limitations including small numbers of patients with CVD, limited data on ethnicity and possible bias arising from undertaking comparisons of cross-sectional data. Previous studies have used data from primary care to examine inequalities in BP measurement and control by deprivation group after the introduction of the Quality and Outcomes Framework (QOF). 10 However, there is currently little information on longer term trends in BP measurement and control and whether known inequalities among age, gender and ethnic groups have persisted. This study examines trends in BP monitoring and control in persons with and without CVD in southwest London between 1998 and It also examines inequalities in BP measurement and control among age, gender, ethnic and socio-economic status (SES) groups over this period. Methods Study setting and data collection The study was conducted in Wandsworth, southwest London, which has a younger, more deprived and more culturally diverse population than is typical for England. 11,12 Twenty-nine of the 34 general practices in the study area participated in the study. Data were extracted directly from individual practice computers using an algorithm applied to each practice to gain all of the relevant data on each patient, including past medical history. We extracted the last BP measurement in each year between 1998 and 2007 from patients aged 45 years, who were registered with practices on the 31 December Our main outcome measures were recording of BP measurement and raised BP. We defined BP as being raised if it was higher than 140/90 mm Hg, as in guidance from the National Institute for Health and Clinical Excellence. 13 Our predictor variables were age, gender, ethnicity, SES and number of comorbid cardiovascular conditions. We categorized age into four groups: 45 54, 55 64, and 75þ years. We categorized ethnicity into four groups (white, black, south Asian and unknown/missing) due to small numbers in individual ethnic subgroups. We assigned each patient to an SES tertile based on their general practice postcode using the Index of Multiple Deprivation (IMD) 2007 (10). The IMD is the most common way to measure arealevel SES in the UK and is composed of several dimensions, such as income, living environment and unemployment. We identified CVD conditions (stroke, diabetes, heart failure, hypertension, CHD, atrial fibrillation or renal failure) in each year using Read and OXMIS codes. Read codes are the clinical classification system used in primary care in the UK; OXMIS codes were used in the past by some general practices but have now been replaced by Read codes. We grouped patients by the number of comorbid CVD conditions (1, 2, 3þ) in each year. Data analysis We calculated the percentage of patients having their BP measured and with raised BP annually by age, gender, ethnic and SES groups. Odds ratios (adjusted for age, sex, IMD of practice and ethnicity) were calculated, with confidence intervals using the Mantel-Haenszel technique. Logistic regression models were used to examine associations among age, sex, ethnicity, deprivation and number of CVD conditions and the measurement and control of BP in 1998 and We used robust standard errors to take account of clustering of patients within general practices. This takes into account that we would expect patients at the same practice to have more similar outcomes than patients from other practices. We fitted an interaction term for year and CVD status to determine whether trends in BP measurement and control differed between patients with and without CVD. Statistical analyses were performed using Stata 10.0 (Stata Corporation, TX, USA). Results Table 1 shows the breakdown of the population in this study. In 2007, there were patients without CVD and with CVD aged 45 years and over in Wandsworth. As expected, the without CVD group was younger than those with CVD with a mean age of 56.0 years in 2007, compared with 66.6 years for the CVD group. There was a much higher percentage with unknown/missing ethnicity among the non-cvd group than among those with CVD (39.9 and 12.4%, respectively), which reflects the high level of ethnicity coding among those with a long-term condition in Wandsworth, as noted elsewhere. 14

3 304 JOURNAL OF PUBLIC HEALTH Table 1 Breakdown of age, ethnic group, deprivation and gender in 2007, by CVD status Total number patients without CVD Percentage of total in this group Total number patients with CVD Percentage of total in this group Overall number of patients in 2007 Age group in years þ Gender Female Male Deprivation group, by practice-level IMD 1 (least deprived) (most deprived) Ethnic background White Black South Asian Unknown/ missing Number of multimorbidities or more Total Trends in BP measurement among individuals with and without CVD The proportion of patients with CVD who have had their BP measured each year increased from 40.3% in 1998 to 91.7% in 2007 (Fig. 1a, Table 2). Older patients were more likely to have their BP measured in 2007 with an adjusted odds ratio (AOR) of 1.39 for those over 75 compared with those between 45 and 54 (95% CI: ), although there was no significant difference between age groups in Men were less likely to have their BP measured in both years (AOR in 2007 of 0.74; 95% CI: ), although the absolute percentage difference has narrowed from 5.6 to 1.9%. Patients with an unknown/missing ethnicity were less likely to have their BP measured in 2007 (AOR, 0.41; 95% CI: ) than white patients, (a) 100 % Meausred during year (b) % With raised Bp 140/ % Measured without CVD % Measured with CVD % Raised BP with CVD % Raised BP without CVD Fig. 1 (a) Improvements in BP measurements among those with and without CVD. (b) Decline in raised BP (140/90) among those with and without CVD. although there was no significant ethnic group difference in In both 1998 and 2007, patients with multiple CVD conditions were more likely to have their BP measured, although the absolute difference between those with one condition and three or more narrowed over this period from 12.6 to 7.2%. The percentage of patients without CVD who had their BP measured in the previous 12 months increased from 13.0 to 36.6% between 1998 and 2007 (Fig. 1a, Table 2). The percentage with their BP measured over the previous 5 years increased from 62.0 to 83.7% between 2002 and Older patients were more likely to have their BP measured, while the absolute difference between patients over 75 years and those between 45 and 54 years increased from 7.5 to 25.9% between 1998 and 2007 (AOR, 2.51; 95% CI: in 2007). The percentage difference for measurement of BP between men and women increased from 6.4 to

4 BLOOD PRESSURE CONTROL IN PRIMARY CARE 305 Table 2 Measurement of BP among those with and without CVD in 1998 and 2007 Characteristic With CVD Without CVD 1998 (%, AOR) 2007 (%, AOR) 1998 (%, AOR) 2007 (%, AOR) Overall % (n) 40.3 (2080/5163) 91.7 (17 863/19 486) 13.0 (2181/16 808) 36.6 (13 337/36 407) Age in years (1) 87.8 (1) 11.4 (1) 31.2 (1) (0.93) 91.1 (1.32)* 14.0 (1.14)* 37.0 (1.27)* (1.05) 93.6 (1.68)* 14.8 (1.12) 49.8 (2.01)* 75þ 46.5 (1.25) 93.0 (1.39)* 18.9 (1.42)* 57.1 (2.51)* Sex Female 42.8 (1) 92.6 (1) 16.1 (1) 45.2 (1) Male 37.2 (0.80)* 90.7 (0.74)* 9.7 (0.62)* 28.9 (0.57)* IMD tertile (1) 90.9 (1) 9.5 (1) 33.2 (1) (2.54) 93.3 (1.41)* 18.0 (2.00) 38.6 (1.21) (2.61) 91.2 (0.98) 12.9 (1.35) 39.7 (1.30) Ethnic group White 41.8 (1) 93.0 (1) 16.2 (1) 46.7 (1) Black 43.6 (1.11) 92.8 (0.98) 17.5 (1.16) 45.8 (1.05) South Asian 34.5 (0.94) 92.7 (0.97) 12.1 (0.89) 43.8 (0.97) Unknown/missing 31.3 (0.66) 83.0 (0.41)* 7.1 (0.46)* 22 (0.37)* Number of CVD conditions (1) 89.6 (1) (1.41)* 95.5 (2.25)* 3 or more 50.9 (1.60)* 96.8 (2.80)* Note that values are adjusted for age, sex, IMD, ethnicity, number of CVD conditions (in patients with CVD only) and practice-level clustering. IMD(1, least deprived; IMD 3, most deprived). *Significant difference at P %. The percentage of patients with an unknown/ missing ethnicity with a BP measurement was significantly lower than among white patients in both 1998 and 2007 (AOR, 0.46; 95% CI: in 1998, and AOR, 0.37; 95% CI: in 2007). Trends in BP control among individuals with and without CVD The percentage of patients with CVD who had raised BP decreased from 56.8 to 36.0% between 1998 and 2007 (Fig. 1b, Table 3). Mean systolic BP decreased from (SD 18.7) to (16.7) mm Hg and mean diastolic BP decreased from 84.2 (10.7) to 78.4 (10.5) mm Hg over the study period. Older patients were more likely to have raised BP in both years, although the absolute difference between those over 75 and those between 45 and 54 has narrowed from 16.1 to 6.1%. South Asian patients with CVD were significantly less likely to have raised BP in both years than their white counterparts, although this difference has narrowed from 13.6 to 9.3%. Patients with multiple CVD conditions were significantly less likely to have raised BP than those with a single CVD condition in The percentage of patients without CVD with raised BP has declined from 31.0 to 25.3% (Fig. 1b, Table 3). Mean systolic BP decreased from (19.1) to (16.6) mm Hg and mean diastolic BP decreased from 80.5 (10.0) to 79.0 (9.6) mm Hg over the study period. Older patients were more likely to have a raised BP (AOR, 4.95; 95% CI: in 1998 and 2.75, 95% CI: in 2007), although the absolute difference here has narrowed from 35.3 to 19.2%. Men were also more likely to have a raised BP in 2007 (AOR, 1.30; 95% CI: ) among this group. Black patients were significantly more likely than white patients to have raised BP in both years (AOR, 1.63;

5 306 JOURNAL OF PUBLIC HEALTH Table 3 Raised BP (.140/90 mm Hg) among those with and without CVD in 1998 and 2007 Characteristic With CVD Without CVD 1998 (%, AOR) 2007 (%, AOR) 1998 (%, AOR) 2007 (%, AOR) Overall % (n) 56.8 (1182/2080) 36.0 (6433/17 863) 31.0 (676/2181) 25.3 (3372/13 337) Age in years (1) 33.1 (1) 19.1 (1) 19.2 (1) (1.38)* 34.2 (1.08) 34.3 (2.12)* 25.7 (1.51)* (1.47)* 36.4 (1.21)* 47.0 (3.57)* 34.1 (2.25)* 75þ 64.1 (1.79)* 39.2 (1.37)* 54.4 (4.95)* 38.4 (2.75)* Sex Female 58.3 (1) 36.3 (1) 31.0 (1) 23.5 (1) Male 54.7 (0.90) 35.7 (1.02) 31.1 (1.07) 27.9 (1.30)* IMD third (1) 38.1 (1) 28.3 (1) 25.5 (1) (1.08) 34.6 (0.81) 31.3 (0.99) 25.5 (0.99) (1.51)* 34.6 (0.83) 33.9 (1.20) 24.8 (1.00) Ethnic group White 58.4 (1) 36.9 (1) 31.8 (1) 24.7 (1) Black 58.9 (1.04) 37.7 (1.09) 41.8 (1.63)* 28.5 (1.34)* South Asian 44.8 (0.65)* 27.6 (0.67)* 25.2 (0.78) 20.9 (0.84) Unknown/missing 53.0 (0.76) 38.8 (1.09) 23.6 (0.79) 26.7 (1.21) Number of CVD conditions (1) 37.2 (1) (0.94) 34.1 (0.85)* 3 or more 55.4 (0.93) 33.5 (0.81)* Note that values are adjusted for age, sex, IMD, ethnicity, number of CVD conditions (in patients with CVD only) and practice-level clustering. IMD (1, least deprived; IMD 3, most deprived). *Significant difference at P % CI: , and 1.34; 95% CI: ), although this absolute difference has narrowed from 10.0 to 3.8%. Differences between the with and without CVD groups Fitting an interaction term for year and CVD status showed that BP measurement [1.20 (95% CI: )] and control [0.93 (95% CI: )] improved at a significantly faster rate over the study period among patients with CVD compared with those without CVD. We can see that there is a multiplicative effect between time and both measurement and control, with the difference in these increasing over time between those with and without CVD. Discussion Main findings of this study This population-based study shows that there have been large improvements in both the measurement and control of BP over the past decade among persons with CVD. Much of this improvement occurred before the implementation of the QOF in Comparatively modest improvements were found among individuals without CVD, although our data indicate that (QOF) targets for BP monitoring in this group (80% having their BP measured every 5 years) are being met. Inequalities in BP control decreased among age, ethnic and SES groups over the study period. But some inequalities were still apparent. For example, black patients without CVD remained more likely to have their BP raised than white patients. Also south Asian patients with CVD were less likely to have raised BP than white patients. Differences between men and women without CVD appeared to increase over the study period, with men being less likely to be measured and more likely to have raised BP than women in Among those with CVD, men were less likely to be measured but were not more likely to have raised BP. This study also found that patients with multiple CVD conditions

6 BLOOD PRESSURE CONTROL IN PRIMARY CARE 307 were both more likely to have their BP measured and controlled than those with a single CVD condition. This suggests that recent quality improvement initiatives in England may have improved risk factor control more in high-risk patients. What is already known on this topic? The relative benefits of population-based strategies, in comparison with high-risk strategies, on cardiovascular health and associated mortality are well established. 15,16 For example, previous work suggests that equivalent reductions in diastolic BP confer a 10-fold greater decrease in coronary heart disease (CHD) mortality among the general population relative to patients with existing CHD. 17 A comparison of primary and secondary prevention strategies recommended in the National Service Framework for CHD also concluded that over CHD per year more cardiovascular events would be prevented by meeting public health and primary prevention targets, compared with events prevented by focusing on those with established disease. 18 Our study builds on previous research that has identified important inequalities in BP control between population groups in the UK. Our finding that black patients were more likely to have raised BP than white patients partly fits in with data from the HSE 2004, which found that black women were more likely to have high BP than the general population, and that black Caribbean men had higher mean systolic BP than the general population. 19 The increasing differences between men and women are consistent with the latest data from the HSE, which cites a particularly large improvement in treatment and control of BP among women which was not mirrored in men. 20 Finally, our finding that patients with multiple conditions are more likely to have their BP both measured and controlled is consistent with previous UK and US evidence on the relationship between number of medical conditions and quality of care generally, 21 among patients with hypertension 22 and those with diabetes. 23 This finding may reflect greater contact with primary care among these patients and the impact of the QOF, a pay for performance programme that incentivises improved management of all of the conditions examined in our study. What this study adds Our findings indicate that the current emphasis on secondary prevention within UK health policy has led to a more rapid reduction in BP levels among patients with CVD than in the general population. While reductions in BP at the population level are undoubtedly more difficult to achieve, the very modest reductions seen in our study over the past decade indicate that important health gains may be being missed. Our study therefore further highlights the importance of increasing investment in primary prevention initiatives known to reduce BP. These initiatives include efforts to halt and then reverse the obesity epidemic and increase physical activity levels. 24 Despite recent positive trends suggesting increased levels of physical activity in England, improvements have been slow and in 2008 only 39% of adult men and 29% of adult women met the Chief Medical Officer s recommendations for physical activity. 25 Finally, while the UK is considered as a world leader in its efforts to reduce population salt intake, it is of concern that the Food Standards Agency s target for reducing population salt intake to 6 g has now been delayed until 2012, as population-based salt reduction has the potential to deliver BP and mortality reductions to large numbers of people, 26 both with and without hypertension. 27 Our findings finally highlight the importance of ongoing assessment of the impact of population and high-risk strategies on inequalities in BP control. Limitations of this study Data were collected on all adult patients registered with 29 of 34 practices in the study area providing a comprehensive picture of BP measurement and control in this urban, ethnically diverse area. However, because we were only able to extract historical data on patients registered in 2007, we lacked information on patients who moved from the area or died during the study period and our sample may be biased towards healthier surviving patients. Further, this meant that the sample size was considerably smaller at the beginning of the study and we may not have had adequate power to detect clinically meaningful differences in BP management. Whilst we had high levels of ethnicity recording among patients with CVD conditions (88%), this was considerably lower among patients without CVD (60%). Our findings relating to ethnic group differences in BP control among patients without CVD should therefore be treated with some caution. We assigned an area-based deprivation score to patients using their general practice postcode. While it would be preferable to employ patient level measures of socio-economic circumstances, such as income or occupational status, these are not routinely recorded in UK general practice. Factors other than the measurement and control of BP would also have been of interest. For example, we do not know whether some of the differences observed in our study are due to prescribing patterns of local doctors, differing adherence to medications or other

7 308 JOURNAL OF PUBLIC HEALTH lifestyle interventions. It would have been informative to examine trends in other risk factors for CVD, such as cholesterol and BMI. However, these remain poorly recorded in general practice information systems at present, i.e. 70% of all patients did not have BMI recorded in We employed a cut point of 140/90 mm Hg for raised BP based on NICE 13 and other guidance for the diagnosis and management of hypertension. 28 This may not reflect the optimal treatment target for individual conditions. The proportion of patients overall with a valid BP reading in 1998 was 19.4% (4621 patients) while by 2007 this had risen to 55.8% ( patients). Part of the improvement in BP control seen in the CVD group may be due to improved ascertainment of cases with borderline hypertension because of this increased measurement of BP over the study period. Conclusion BP control has improved more markedly among those with CVD, compared with those without CVD, in the UK over the past decade. This finding highlights a need to re-evaluate the focus on secondary prevention in the current UK health policy. Inequalities in BP control decreased among age, ethnic and SES groups over the study period. However, differences in BP control between black and white patients have persisted and have increased between men and women. Acknowledgments We thank the 29 practices that took part in this study and Dr Jeremy Gray for his help in planning the data collection, and Dr Simon de Lusignan and his team for carrying out the data extraction. Funding A.L. is funded by the National Institute for Health Research. C.M. is funded by the Higher Education Funding Council for England and the National Institute for Health Research. A.B. and the Dr Foster Unit are largely funded by Dr Foster Intelligence, a joint venture with the NHS Information Centre. The Department of Primary Care and Public Health at Imperial College is grateful for support from the National Institute for Health Research Biomedical Research Centre scheme, the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme, and the Imperial Centre for Patient Safety and Service Quality; we are also grateful for past support from the Medical Research Council and the Engineering and Physical Sciences Research Council. References 1 Ezzati M., Lopez AD, Rodgers A et al. Selected major risk factors and global and regional burden of disease. Lancet 2002;360(9343): He FJ, MacGregor GA. Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year. J Hum Hypertens 2003; 17(7): British Heart Foundation. Statistics Online (27 May 2010, date last accessed). 4 Capewell S, O Flaherty M. What explains declining coronary mortality? Lessons and warnings. Heart 2008;94(9): Food Standards Agency. Food Standards Agency Salt Reduction Strategy (13 April 2010, date last accessed). 6 Department of Health. The Coronary Heart Disease National Service Framework: Building on Excellence, Maintaining Progress. Department of Health Department of Health, National Service Framework for Older People. Department of Health Department of Health, Putting Prevention First Vascular Checks: Risk Assessment and Management. Department of Health Primatesta P, Poulter NR. Improvement in hypertension management in England: results from the Health Survey for England J Hypertens 2006;24(6): Ashworth M, Medina J, Morgan M. Effect of social deprivation on blood pressure monitoring and control in England: a survey of data from the quality and outcomes framework. BMJ 2008;337:a Department of Communities and Local Government. Index of Multiple Deprivation communities/neighbourhoodrenewal/deprivation/deprivation07/ (12 April 2010, date last accessed). 12 Office for National Statistics. The Census in England and Wales (2010 April 12th, date last accessed). 13 National Institute for Health and Clinical Excellence. NICE Clinical Guideline 34: Hypertension: Management of Hypertension in Adults in Primary Care cg034quickrefguide.pdf (3 March 2010, date last accessed). 14 Millett C, Gray J, Bottle A, Majeed A. Ethnic disparities in blood pressure management in patients with hypertension after the introduction of pay for performance. Ann Fam Med, 2008;6(6): Rose G. The Strategy of Preventive Medicine. Oxford: Oxford University Press Lawes CMM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke an overview of published reviews. Stroke 2004;35(3): Unal B, Critchley JA, Capewell S. Modelling the decline in coronary heart disease deaths in England and Wales, : comparing contributions from primary prevention and secondary prevention. Br Med J 2005;331(7517): Gemmel IH, Heller RF, Payne KK et al. Potential population impact of the UK government strategy for reducing the burden of

8 BLOOD PRESSURE CONTROL IN PRIMARY CARE 309 Coronary Heart Disease in England: comparing primary and secondary prevention strategies. Qual Saf Health Care, 2006;15: Sproston K, Mindell J. (eds). Health Survey for England 2004 The Health of Ethnic Minority Groups. The NHS Information Centre for health and social care Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England: results from the Health Survey for England Hypertension 2009;53(3): Higashi T, Wenger NS, Adams JL et al. Relationship between number of medical conditions and quality of care. N Engl J Med 2007;356(24): Petersen LA, Woodard LD, Henderson LM et al. Will hypertension performance measures used for pay-for-performance programs penalize those who care for medically complex patients? Circulation 2009;119(23): Millett C, Bottle A, Ng A et al. Pay for performance and the quality of diabetes management in individuals with and without co-morbid medical conditions. J R Soc Med 2009;102(9): Rennie KL, Jebb SA. Prevalence of obesity in Great Britain. Obes Rev 2005;6(1): Information Centre. Health Survey for England 2008: Physical Activity and Fitness. The NHS Information Centre for health and social care Bibbins-Domingo K, Chertow GM, Coxson PG et al. Projected effect of dietary salt reductions on future cardiovascular disease. NEnglJ Med 2010;362(7): He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension 2003;42(6): Graham I, Atar D, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007;28(19):

Impacts of a national strategy to reduce population salt intake in England Anthony Laverty

Impacts of a national strategy to reduce population salt intake in England Anthony Laverty Impacts of a national strategy to reduce population salt intake in England Anthony Laverty Importance of salt intake World Health Organization estimates high blood pressure responsible for ~50% cardiovascular

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:

More information

Getting serious about preventing cardiovascular disease

Getting serious about preventing cardiovascular disease Getting serious about preventing cardiovascular disease Southwark s Experience Professor Kevin Fenton Director of Health and Wellbeing, London Borough of Southwark February 2018 Twitter: @ProfKevinFenton

More information

Inequalities in health due to ethnicity and social deprivation an analysis of primary care data from one inner city area over a three year period

Inequalities in health due to ethnicity and social deprivation an analysis of primary care data from one inner city area over a three year period Inequalities in health due to ethnicity and social deprivation an analysis of primary care data from one inner city area over a three year period Report to the National Audit Office Peter Schofield, PhD

More information

NHS Wandsworth, 3rd floor Wimbledon Bridge House, Hartfield Road, London SW19 3RU

NHS Wandsworth, 3rd floor Wimbledon Bridge House, Hartfield Road, London SW19 3RU Impact of the 2004 General Practitioner Contract on health improvement and inequalities in cardiovascular disease and diabetes: findings from a systematic review and national and local quantitative studies

More information

The Effects of Pay for Performance on Disparities in Stroke, Hypertension, and Coronary Heart Disease Management: Interrupted Time Series Study

The Effects of Pay for Performance on Disparities in Stroke, Hypertension, and Coronary Heart Disease Management: Interrupted Time Series Study in Stroke, Hypertension, and Coronary Heart Disease Management: Interrupted Time Series Study John Tayu Lee*, Gopalakrishnan Netuveli, Azeem Majeed, Christopher Millett Department of Primary Care and Public

More information

Ethnic group differences in CVD risk estimates using JBS2 and QRISK2 risk scores. Dr Andrew R H Dalton

Ethnic group differences in CVD risk estimates using JBS2 and QRISK2 risk scores. Dr Andrew R H Dalton Ethnic group differences in CVD risk estimates using JBS2 and QRISK2 risk scores Dr Andrew R H Dalton Cardiovascular Diseases CVD & Ethnic inequalities Standardised mortality ratios (SMR) for heart disease

More information

Estimated number of people with hypertension. Significantly higher than the. Proportion. diagnosed with. hypertension

Estimated number of people with hypertension. Significantly higher than the. Proportion. diagnosed with. hypertension Hypertension profile Background Diagnosis and control of hypertension in * This profile compares with data for, authorities in the South East region and the Office for National Statistics (ONS) group of

More information

Hypertension Profile. NHS High Weald Lewes Havens CCG. Background

Hypertension Profile. NHS High Weald Lewes Havens CCG. Background NHS High Weald Lewes Havens Background Hypertension Profile Diagnosis and control of in NHS High Weald Lewes Havens * This profile compares NHS High Weald Lewes Havens with data for, a group of similar

More information

Time Series Analysis for selected clinical indicators from the Quality and Outcomes Framework

Time Series Analysis for selected clinical indicators from the Quality and Outcomes Framework Time Series Analysis for selected clinical indicators from the Quality and Outcomes Framework 21-26 Title Document Type Time Series Analysis for selected clinical indicators from the Quality and Outcomes

More information

Coronary heart disease statistics edition. Steven Allender, Viv Peto, Peter Scarborough, Anna Boxer and Mike Rayner

Coronary heart disease statistics edition. Steven Allender, Viv Peto, Peter Scarborough, Anna Boxer and Mike Rayner Coronary heart disease statistics 2007 edition Steven Allender, Viv Peto, Peter Scarborough, Anna Boxer and Mike Rayner Health Promotion Research Group Department of Public Health, University of Oxford

More information

National study. Closing the gap. Tackling cardiovascular disease and health inequalities by prescribing statins and stop smoking services

National study. Closing the gap. Tackling cardiovascular disease and health inequalities by prescribing statins and stop smoking services National study Closing the gap Tackling cardiovascular disease and health inequalities by prescribing statins and stop smoking services September 2009 About the Care Quality Commission The Care Quality

More information

NICE Indicator Programme. Consultation on proposed amendments to current QOF indicators

NICE Indicator Programme. Consultation on proposed amendments to current QOF indicators NICE Indicator Programme Consultation on proposed amendments to current QOF s Consultation dates: 18 July to 1 August 2018 This document outlines proposed amendments to a small number of QOF s in the diabetes

More information

Guideline scope Hypertension in adults (update)

Guideline scope Hypertension in adults (update) NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Hypertension in adults (update) This guideline will update the NICE guideline on hypertension in adults (CG127). The guideline will be

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Peripheral arterial disease Potential output:

More information

Professor Norman Sharpe. Heart Foundation West Coast

Professor Norman Sharpe. Heart Foundation West Coast Professor Norman Sharpe Heart Foundation West Coast Primary Care the Keystone to Heart Health Improvement Norman Sharpe June 2013 The heart health continuum and the keystone position The culprit disease

More information

Preventive Cardiology Scientific evidence

Preventive Cardiology Scientific evidence Preventive Cardiology Scientific evidence Professor David A Wood Garfield Weston Professor of Cardiovascular Medicine International Centre for Circulatory Health Imperial College London Primary prevention

More information

Pay for performance, inequalities, and diabetes care

Pay for performance, inequalities, and diabetes care Pay for performance, inequalities, and diabetes care Submitted for the degree of Doctor of Philosophy Riyadh Alshamsan 2011 Imperial College London School of Public Health Abstract Background: The Quality

More information

Population intermediate outcomes of diabetes under pay for performance incentives in England from 2004 to 2008

Population intermediate outcomes of diabetes under pay for performance incentives in England from 2004 to 2008 Diabetes Care Publish Ahead of Print, published online December 23, 2008 Diabetes outcomes and pay for performance Population intermediate outcomes of diabetes under pay for performance incentives in England

More information

Costing the burden of ill health related to physical inactivity for Scotland

Costing the burden of ill health related to physical inactivity for Scotland Costing the burden of ill health related to physical inactivity for Scotland Written by Dr Nick Townsend, Senior Researcher, BHF Centre on Population Approaches for Non-Communicable Disease Prevention,

More information

Dianne Johnson / Lee Panter / Sarah McNulty

Dianne Johnson / Lee Panter / Sarah McNulty Cardiovascular Disease (heart disease and stroke) READER INFORMATION Need Identified Lead Author Cardiovascular Disease Dianne Johnson / Lee Panter / Sarah McNulty Date completed 07/02/11 Director approved

More information

Obesity in the United Kingdom: Analysis of QRESEARCH data

Obesity in the United Kingdom: Analysis of QRESEARCH data Obesity in the United Kingdom: Analysis of QRESEARCH data Authors: Professor Julia Hippisley-Cox Ronan Ryan Professor of Clinical Epidemiology and General Practice Research Fellow/Program Institution University

More information

THE NEW ARMENIAN MEDICAL JOURNAL DISTRIBUTION, AWARENESS, TREATMENT, AND CONTROL OF ARTERIAL HYPERTENSION IN YEREVAN (ARMENIA)

THE NEW ARMENIAN MEDICAL JOURNAL DISTRIBUTION, AWARENESS, TREATMENT, AND CONTROL OF ARTERIAL HYPERTENSION IN YEREVAN (ARMENIA) THE NEW ARMENIAN MEDICAL JOURNAL Vol.5 (2011), Nо 2, p.29-34 DISTRIBUTION, AWARENESS, TREATMENT, AND CONTROL OF ARTERIAL HYPERTENSION IN YEREVAN (ARMENIA) Zelveian P.H. 1, 2, Podosyan G.A. 2 1 Institute

More information

Diabetes. Ref HSCW 024

Diabetes. Ref HSCW 024 Diabetes Ref HSCW 024 Why is it important? Diabetes is an increasingly common, life-long, progressive but largely preventable health condition affecting children and adults, causing a heavy burden on health

More information

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database open access Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database Yana Vinogradova, 1 Carol Coupland, 1 Peter Brindle, 2,3 Julia Hippisley-Cox

More information

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study Statistical modelling details We used Cox proportional-hazards

More information

A logical approach to planning health care services in relation to need Dr Christopher A Birt University of Liverpool

A logical approach to planning health care services in relation to need Dr Christopher A Birt University of Liverpool EUREGIO III A logical approach to planning health care services in relation to need Dr Christopher A Birt University of Liverpool PURPOSE OF A HEALTH SERVICE To utilise resources allocated to the health

More information

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Katherine Baldock Catherine Chittleborough Patrick Phillips Anne Taylor August 2007 Acknowledgements This project was made

More information

The management of diabetes

The management of diabetes MEDICINE DIGEST STATINS The management of diabetes should include efforts to prevent, or delay, the onset of cardiovascular disease. Statins have been shown to lower cardiovascular risk in diabetes and

More information

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less Chapter 5: Joint Analyses with UK Transplant in England and Wales; Access to the Renal Transplant Waiting List, Time to Listing, Diabetic Access to Transplantation and the Influence of Social Deprivation

More information

WHO Framework Convention on Tobacco Control. Submission from the National Heart Forum (UK)

WHO Framework Convention on Tobacco Control. Submission from the National Heart Forum (UK) WHO Framework Convention on Tobacco Control Submission from the National Heart Forum (UK) Introduction The UK s National Heart Forum (NHF) welcomes the opportunity to contribute to the development of the

More information

Management of ischaemic heart disease in primary care: towards better practice

Management of ischaemic heart disease in primary care: towards better practice Journal of Public Health Medicine Vol. 21, No. 2, pp. 179 184 Printed in Great Britain Management of ischaemic heart disease in primary care: towards better practice Krish Thiru, Jeremy Gray and Azeem

More information

Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government

Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease Produced on behalf of NHS Wales and Welsh Government April 2018 Table of Contents Introduction... 3 Variation in health services...

More information

Peterborough City Council Cardiovascular Disease Joint Strategic Needs Assessment SUMMARY. Section Number Section Page Number

Peterborough City Council Cardiovascular Disease Joint Strategic Needs Assessment SUMMARY. Section Number Section Page Number Cardiovascular Disease Joint Strategic Needs Assessment Summary 2015 1 Contents - Section Number Section Page Number 1 Introduction and Background to the CVD JSNA 3 1.1 Joint Strategic Needs Assessments

More information

Economically efficient approaches to address chronic disease in developing countries

Economically efficient approaches to address chronic disease in developing countries Economically efficient approaches to address chronic disease in developing countries Thomas A. Gaziano MD MSc Division of Cardiovascular Medicine Brigham & Women s Hospital Harvard Medical School Center

More information

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group Repeat ischaemic heart disease audit of primary care patients (2002-2003): Comparisons by age, sex and ethnic group Baseline-repeat ischaemic heart disease audit of primary care patients: a comparison

More information

POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK

POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK Author: CHARLOTTE SIMPSON, SPECIALTY REGISTAR PUBLIC HEALTH (ST3), CHESHIRE EAST COUNCIL/MERSEY DEANERY SUMMARY

More information

Increasing Awareness of Hypertension in Africa : Road to Success

Increasing Awareness of Hypertension in Africa : Road to Success Increasing Awareness of Hypertension in Africa : Road to Success Neil R Poulter International Centre for Circulatory Health and Imperial Clinical Trials Unit Imperial College London President of International

More information

Four Years of NHS Health Checks in Barnsley - Outcomes and Inequalities

Four Years of NHS Health Checks in Barnsley - Outcomes and Inequalities Four Years of NHS Health Checks in Barnsley - Outcomes and Inequalities Summary After four years of NHS Health Checks, Barnsley has access to aggregated data on over 47,000 people. This data was analysed

More information

Britain against Cancer APPG Cancer Meeting 2009 Research & Technologies Workshop

Britain against Cancer APPG Cancer Meeting 2009 Research & Technologies Workshop Britain against Cancer APPG Cancer Meeting 2009 Research & Technologies Workshop Researching inequality and cancer - what we know and what requires further research David Forman, Michael Chapman, Jon Shelton

More information

Disability, dementia and frailty in later life - mid-life approaches to prevention. Population based approaches to prevention

Disability, dementia and frailty in later life - mid-life approaches to prevention. Population based approaches to prevention Section A: CPH to complete Name: Job titles: Address: Robin Ireland, Alexandra Holt & Simon Capewell* CEO & Researcher, Health Equalities Group; *Professor of Clinical Epidemiology Health Equalities Group,

More information

Coronary heart disease and stroke

Coronary heart disease and stroke 4 Coronary heart disease and stroke Overview of cardiovascular disease Cardiovascular disease (CVD), also called circulatory disease, describes a group of diseases which are caused by blockage or rupture

More information

Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia

Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia (2004) 18, 545 551 & 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh REVIEW ARTICLE Prevalence, awareness, treatment and control of hypertension in North America,

More information

NHS England Impact Analysis of implementing NHS Diabetes Prevention Programme, 2016 to 2021

NHS England Impact Analysis of implementing NHS Diabetes Prevention Programme, 2016 to 2021 NHS England Impact Analysis of implementing NHS Diabetes Prevention Programme, 2016 to 2021 1. Purpose The purpose of this document is to describe both the estimated resource implications to NHS England

More information

European Journal of Cardiovascular Prevention & Rehabilitation

European Journal of Cardiovascular Prevention & Rehabilitation European Journal of Cardiovascular Prevention & Rehabilitation http://cpr.sagepub.com/ Prevalence of cardiovascular disease risk amongst the population eligible for the NHS Health Check Programme Andrew

More information

A mixed methods evaluation of a diabetes peer support scheme in an inner city London area

A mixed methods evaluation of a diabetes peer support scheme in an inner city London area A mixed methods evaluation of a diabetes peer support scheme in an inner city London area Introduction The diabetes mentor scheme was initiated across GP practices in an inner city London area covering

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

NHS Health Check: Tackling health inequalities in community settings

NHS Health Check: Tackling health inequalities in community settings NHS Health Check: Tackling health inequalities in community settings Andrea Hare: Health and Wellbeing Leader, PHE (Feb 27 th 2014) Andrea.hare@phe.gov.uk Aim of the workshop: To gain an understanding

More information

International model for prevention of chronic disease: Finland experience

International model for prevention of chronic disease: Finland experience International model for prevention of chronic disease: Finland experience Erkki Vartiainen, MD, Professor, Assistant Director General 06/12/2011 Erkki Vartiainen 1 2 Start of the North Karelia project

More information

National Child Measurement Programme Changes in children s body mass index between 2006/07 and 2010/11

National Child Measurement Programme Changes in children s body mass index between 2006/07 and 2010/11 National Child Measurement Programme Changes in children s body mass index between 2006/07 and 2010/11 Delivered by NOO on behalf of the Public Health Observatories in England Published: March 2012 NOO

More information

HIGH BLOOD PRESSURE. How can we do better?

HIGH BLOOD PRESSURE. How can we do better? HIGH BLOOD PRESSURE How can we do better? Review date: February 2018 This publication includes practical guidance from GPs, nurses and pharmacists on how you can improve detection and management of high

More information

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures THE CVD CHALLENGE IN NORTHERN IRELAND Together we can save lives and reduce NHS pressures The challenge of CVD continues today. Around 225,000 people in Northern Ireland live with the burden of cardiovascular

More information

Healtheast CCG - developing an understanding of health and wellbeing needs. Public Health NHS Norfolk and Waveney Cluster and Norfolk County Council

Healtheast CCG - developing an understanding of health and wellbeing needs. Public Health NHS Norfolk and Waveney Cluster and Norfolk County Council Healtheast CCG - developing an understanding of health and wellbeing needs Public Health NHS Norfolk and Waveney Cluster and Norfolk County Council Acknowledgements Norfolk County Council Children s Services

More information

Heidi Mochari-Greenberger, Ph.D., M.P.H., 1 Thomas Mills, M.S., 2 Susan L. Simpson, Ph.D., 2 and Lori Mosca, M.D., M.P.H., Ph.D. 1

Heidi Mochari-Greenberger, Ph.D., M.P.H., 1 Thomas Mills, M.S., 2 Susan L. Simpson, Ph.D., 2 and Lori Mosca, M.D., M.P.H., Ph.D. 1 JOURNAL OF WOMEN S HEALTH Volume 19, Number 7, 2010 ª Mary Ann Liebert, Inc. DOI: 10.1089=jwh.2009.1749 Original Article Knowledge, Preventive Action, and Barriers to Cardiovascular Disease Prevention

More information

2. Quality and Outcomes Framework: new NICE recommendations

2. Quality and Outcomes Framework: new NICE recommendations Proposed Changes to the GMS Contract 2013/14 1. GP pay and expenses uplift It is proposed GP pay and expenses is uplifted by 1.5%. This increased investment will allow for an average pay increase of up

More information

Greenwich Hypertension (High Blood Pressure) Profile

Greenwich Hypertension (High Blood Pressure) Profile Joint Strategic Needs Assessment Greenwich Hypertension (High Blood Pressure) Profile September 2016 Authors: Alexandra Wyszkowska 1 September 2016 2 Contents Table of Figures... 4 Summary... 5 Background...

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Diabetes dietary review Potential output: Recommendations

More information

Manchester, Manchester, United Kingdom. Department of Primary Health Care, University of Oxford, Oxford, United Kingdom. United Kingdom.

Manchester, Manchester, United Kingdom. Department of Primary Health Care, University of Oxford, Oxford, United Kingdom. United Kingdom. Recorded quality of primary care for patients with diabetes in England before and after the introduction of a financial incentive scheme: longitudinal observational study. Evangelos Kontopantelis, research

More information

Primary hypertension in adults

Primary hypertension in adults Primary hypertension in adults NICE provided the content for this booklet which is independent of any company or product advertised Hypertension Welcome NICE published an updated guideline on the diagnosis

More information

Cardiovascular disease profile

Cardiovascular disease profile Background This chapter of the Cardiovascular disease profiles focuses on risk factors for cardiovascular disease and is produced by the National Cardiovascular Intelligence Network (NCVIN). The profiles

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: overview bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view

More information

NHS Health Check: Diabetes Filter Consultation

NHS Health Check: Diabetes Filter Consultation NHS Health Check: Diabetes Filter Consultation About Public Health England Public Health England exists to protect and improve the nation's health and wellbeing, and reduce health inequalities. It does

More information

NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN)

NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN) NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia Produced by: National Cardiovascular Intelligence Network (NCVIN) Date: August 2015 About Public Health England Public Health England

More information

GOVERNING BODY REPORT

GOVERNING BODY REPORT GOVERNING BODY REPORT DATE OF MEETING: 20th September 2012 TITLE OF REPORT: KEY MESSAGES: NHS West Cheshire Clinical Commissioning Group has identified heart disease as one of its six strategic clinical

More information

2. Morbidity. Incidence

2. Morbidity. Incidence 2. Morbidity This chapter reports on country-level estimates of incidence, case fatality and prevalence of the following conditions: myocardial infarction (heart attack), stroke, angina and heart failure.

More information

Trends in Hospital Admissions For Diabetes Complications

Trends in Hospital Admissions For Diabetes Complications Trends in Hospital Admissions For Diabetes Complications 2004-2010 Elizabeth Cecil - Research Assistant, DPCPH, Imperial College Michael Soljak Clinical Research Fellow, DPCPH, Imperial College Outline

More information

CASE STUDY: Measles Mumps & Rubella vaccination. Health Equity Audit

CASE STUDY: Measles Mumps & Rubella vaccination. Health Equity Audit CASE STUDY: Measles Mumps & Rubella vaccination Health Equity Audit October 2007 Dr Marie-Noelle Vieu Public Health - Lambeth PCT 1 Contents 1. Executive summary page: Lambeth PCT MMR vaccination Equity

More information

Commissioning for value focus pack

Commissioning for value focus pack Commissioning for value focus pack Clinical commissioning group: NHS MILTON KEYNES CCG Focus area: Cardiovascular disease (CVD) pathway Version 2 June 2014 Contents 1. Background and context About the

More information

Treatment of hypertension to achieve blood pressure control

Treatment of hypertension to achieve blood pressure control Treatment of hypertension to achieve blood pressure control Item Type Report Authors Peter Mas-Mollinedo Publisher Irish Heart Foundation (IHF) Download date 01/11/2018 18:07:44 Link to Item http://hdl.handle.net/10147/310910

More information

MONITORING UPDATE. Authors: Paola Espinel, Amina Khambalia, Carmen Cosgrove and Aaron Thrift

MONITORING UPDATE. Authors: Paola Espinel, Amina Khambalia, Carmen Cosgrove and Aaron Thrift MONITORING UPDATE An examination of the demographic characteristics and dietary intake of people who meet the physical activity guidelines: NSW Population Health Survey data 2007 Authors: Paola Espinel,

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME QOF indicator area: Diabetes Briefing paper Potential output: Recommendations

More information

Total and attributable healthcare costs of hypertension: Historic and projected costs in Alberta, Canada

Total and attributable healthcare costs of hypertension: Historic and projected costs in Alberta, Canada Total and attributable healthcare costs of hypertension: Historic and projected costs in Alberta, Canada Kerry McBrien, MD, MPH Departments of Family Medicine and Community Health Sciences, University

More information

Socioeconomic status risk factors for cardiovascular diseases by sex in Korean adults

Socioeconomic status risk factors for cardiovascular diseases by sex in Korean adults , pp.44-49 http://dx.doi.org/10.14257/astl.2013 Socioeconomic status risk factors for cardiovascular diseases by sex in Korean adults Eun Sun So a, Myung Hee Lee 1 * a Assistant professor, College of Nursing,

More information

Cardiovascular Risk Assessment and Management Making a Difference

Cardiovascular Risk Assessment and Management Making a Difference Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy

More information

RISK FACTORS FOR HYPERTENSION IN INDIA AND CHINA: A COMPARATIVE STUDY

RISK FACTORS FOR HYPERTENSION IN INDIA AND CHINA: A COMPARATIVE STUDY Health and Population - Perspectives and Issues 37 (1 & 2), 40-49, 2014 RISK FACTORS FOR HYPERTENSION IN INDIA AND CHINA: A COMPARATIVE STUDY FuJun Wang*, V. K. Tiwari** and Hao Wang*** ABSTRACT To identify

More information

14. HEALTHY EATING INTRODUCTION

14. HEALTHY EATING INTRODUCTION 14. HEALTHY EATING INTRODUCTION A well-balanced diet is important for good health and involves consuming a wide range of foods, including fruit and vegetables, starchy whole grains, dairy products and

More information

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY.

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY. OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY THE OREGON DEPARTMENT OF HUMAN SERVICES HEALTH SERVICES HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM www.healthoregon.org/hpcdp Contents

More information

National Chronic Kidney Disease Audit

National Chronic Kidney Disease Audit National Chronic Kidney Disease Audit // National Report: Part 2 December 2017 Commissioned by: Delivered by: // Foreword by Fiona Loud And if, as part of good, patient-centred care, a record of your condition(s),

More information

National Diabetes Audit

National Diabetes Audit National Diabetes Audit Executive Summary Key findings about the quality of care for people with diabetes in England and Wales Report for the audit period 2007-2008 Prepared in partnership with: Executive

More information

Economic costs of physical inactivity. Evidence Briefing. physical inactivity

Economic costs of physical inactivity. Evidence Briefing. physical inactivity 1 Economic costs of physical inactivity Evidence Briefing Costs Economic of costs of Physical physical inactivity Inactivity Contents Introduction 1 Costs to the UK healthcare system and economy 1 The

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Developmental Perspectives on Health Disparities from Conception Through Adulthood Risk Factors for Heart Disease Philip Greenland, MD Harry W. Dingman Professor Chair, Department of Preventive Medicine

More information

Health Benefits of Lowering Sodium Intake in the US

Health Benefits of Lowering Sodium Intake in the US Health Benefits of Lowering Sodium Intake in the US Lawrence J Appel, MD, MPH Professor of Medicine, Epidemiology and International Health (Human Nutrition) Director, Welch Center for Prevention, Epidemiology

More information

Changing the Course of Diabetes: Turning Hope into Reality

Changing the Course of Diabetes: Turning Hope into Reality Indian Health Service Special Diabetes Program for Indians 2014 Report to Congress Changing the Course of Diabetes: Turning Hope into Reality In response to the burgeoning diabetes epidemic among American

More information

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Putting NICE guidance into practice Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Published: July 2014 This costing report accompanies Lipid modification:

More information

Let s Talk About Weight: A step-by-step guide to brief interventions with adults for health and care professionals

Let s Talk About Weight: A step-by-step guide to brief interventions with adults for health and care professionals : A step-by-step guide to brief interventions with adults for health and care professionals About Public Health England Public Health England exists to protect and improve the nation s health and wellbeing,

More information

National Diabetes Insulin Pump Audit, England and Wales

National Diabetes Insulin Pump Audit, England and Wales National Diabetes Insulin Pump Audit, 2016-2017 England and Wales V0.22 7 March 2017 Prepared in collaboration with: The Healthcare Quality Improvement Partnership (HQIP). The National Diabetes Audit (NDA)

More information

UK stroke incidence, mortality and cardiovascular risk management 1999e2008: time-trend analysis from the General Practice Research Database

UK stroke incidence, mortality and cardiovascular risk management 1999e2008: time-trend analysis from the General Practice Research Database Open Access To cite: Lee S, Shafe ACE, Cowie MR. UK stroke incidence, mortality and cardiovascular risk management 1999e2008: time-trend analysis from the General Practice Research Database. BMJ Open 2011;1:

More information

The problem of uncontrolled hypertension

The problem of uncontrolled hypertension (2002) 16, S3 S8 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh The problem of uncontrolled hypertension Department of Public Health and Clinical Medicine, Norrlands

More information

National Child Measurement Programme. Changes in children s body mass index between 2006/7 and 2014/15

National Child Measurement Programme. Changes in children s body mass index between 2006/7 and 2014/15 National Child Measurement Programme Changes in children s body mass index between 2006/7 and 2014/15 Version 1.0/ October 2016 Changes in Children s Body Mass Index btween 2006/7 and 2014/15 About Public

More information

Supplemental tables/figures

Supplemental tables/figures Supplemental tables/figures Table S:Baseline variables included in calculation of QRISK and Framingham scores Ethnicity (European, Indian Pakistani, Bangladeshi, Black African, Black Caribbean) QRISK Age,

More information

Tackling atrial fibrillation the health economics evidence

Tackling atrial fibrillation the health economics evidence Tackling atrial fibrillation the health economics evidence Professor Gary Ford,CBE Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford University Hospitals

More information

Relationship between body mass index and length of hospital stay for gallbladder disease

Relationship between body mass index and length of hospital stay for gallbladder disease Journal of Public Health Vol. 30, No. 2, pp. 161 166 doi:10.1093/pubmed/fdn011 Advance Access Publication 27 February 2008 Relationship between body mass index and length of hospital stay for gallbladder

More information

Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women

Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women (Lancet. 2017 Mar 25;389(10075):1229-1237) 1 Silvia STRINGHINI Senior

More information

RESEARCH. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore

RESEARCH. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore Julia Hippisley-Cox, professor of clinical epidemiology and general practice, 1 Carol Coupland,

More information

Cost implications of implementing NICE guideline on chest pain in rapid access chest pain clinics: an audit and cost analysis

Cost implications of implementing NICE guideline on chest pain in rapid access chest pain clinics: an audit and cost analysis Journal of Public Health Advance Access published January 22, 2012 Journal of Public Health pp. 1 6 doi:10.1093/pubmed/fdr118 Cost implications of implementing NICE guideline on chest pain in rapid access

More information

Vascular checks a vascular risk assessment and management. Heather White Deputy Branch Head Vascular Programme

Vascular checks a vascular risk assessment and management. Heather White Deputy Branch Head Vascular Programme Vascular checks a vascular risk assessment and management Heather White Deputy Branch Head Vascular Programme Three Questions (1) What is the starting point? (2) Where are we now? (3) What happens next?

More information

JSNA Data Refresh 2013/14 Diabetes Barnet

JSNA Data Refresh 2013/14 Diabetes Barnet JSNA Data Refresh 2013/14 Diabetes Barnet Diabetes is a common life-long health condition. There are 3 million people diagnosed with diabetes in the UK. Type 2 diabetes is a largely preventable disease

More information

DEPARTMENT OF GENERAL MEDICINE WELCOMES

DEPARTMENT OF GENERAL MEDICINE WELCOMES DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global

More information

Hypertension awareness, treatment, and control

Hypertension awareness, treatment, and control O r i g i n a l P a p e r Prevalence of Self-Reported High Blood Pressure Awareness, Advice Received From Health Professionals, and Actions Taken to Reduce High Blood Pressure Among US Adults Healthstyles

More information